Mon, January 9, 2012
Sun, January 8, 2012
Sat, January 7, 2012
Fri, January 6, 2012
Thu, January 5, 2012
Wed, January 4, 2012
Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011
Thu, December 22, 2011
[ Thu, Dec 22nd 2011 ] - Market Wire
A View from the Top

Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. 0th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Tuesday, January 3rd 2012 at 5:36 GMT by Market Wire   Print publication without navigation


Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference -- CAMBRIDGE, Mass., Jan. 3, 2012 /PRNewswire/ --

Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference

[ ]

CAMBRIDGE, Mass., Jan. 3, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: [ IDIX ]) announced today that Idenix management will present a corporate overview at the 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012 at 2:00 p.m. PST at the Westin St. Francis in San Francisco.  

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at [ www.idenix.com ]. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to [ http://www.idenix.com ].

Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)

 

SOURCE Idenix Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.idenix.com ]


Publication Contributing Sources